NOGUERA, NELIDA INES
 Distribuzione geografica
Continente #
NA - Nord America 10.814
AS - Asia 1.437
EU - Europa 1.235
SA - Sud America 212
AF - Africa 28
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.731
Nazione #
US - Stati Uniti d'America 10.761
SG - Singapore 703
IT - Italia 341
CN - Cina 254
BR - Brasile 184
RU - Federazione Russa 179
VN - Vietnam 144
IE - Irlanda 133
HK - Hong Kong 123
DE - Germania 116
UA - Ucraina 109
FR - Francia 93
GB - Regno Unito 56
KR - Corea 47
PL - Polonia 44
FI - Finlandia 42
JP - Giappone 41
IN - India 38
CA - Canada 33
NL - Olanda 31
SE - Svezia 24
ID - Indonesia 14
MX - Messico 14
AT - Austria 13
BD - Bangladesh 13
BE - Belgio 12
TR - Turchia 12
ES - Italia 11
IQ - Iraq 9
AR - Argentina 7
ZA - Sudafrica 7
GR - Grecia 6
TN - Tunisia 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
EG - Egitto 5
CO - Colombia 4
DK - Danimarca 4
EC - Ecuador 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
PE - Perù 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
PK - Pakistan 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TZ - Tanzania 1
Totale 13.731
Città #
Woodbridge 2.662
Wilmington 2.530
Houston 2.527
Singapore 436
Fairfield 335
Chandler 257
Ann Arbor 243
Ashburn 238
San Jose 162
Seattle 141
Cambridge 131
Rome 125
Hong Kong 122
Dublin 116
Beijing 101
Dearborn 92
Medford 83
Dallas 82
Jacksonville 76
New York 71
Santa Clara 60
Council Bluffs 59
Ho Chi Minh City 54
Los Angeles 45
Lawrence 39
The Dalles 34
Hanoi 32
Lauterbourg 31
Tokyo 31
Kraków 30
Buffalo 26
Moscow 24
Menlo Park 21
San Diego 21
Milan 20
São Paulo 19
Zhengzhou 18
Colorado Springs 15
Nuremberg 15
Chennai 14
Hackensack 13
Helsinki 13
Jakarta 13
London 13
Brussels 12
Chicago 10
Munich 10
Seoul 10
Amsterdam 9
Atlanta 9
Brooklyn 9
Engelhard 9
Montreal 9
Perugia 9
Toronto 9
Warsaw 9
Kunming 8
La Veta 8
Verona 8
Boardman 7
Frankfurt am Main 7
Norwalk 7
Center 6
Falls Church 6
Haiphong 6
Mülheim 6
Orem 6
Redondo Beach 6
Redwood City 6
Shanghai 6
Vienna 6
Brasília 5
Cairo 5
Columbus 5
Curitiba 5
Da Nang 5
Paris 5
Phoenix 5
Stockholm 5
Tashkent 5
Bari 4
Belo Horizonte 4
Blumenau 4
Brno 4
Creede 4
Florence 4
Istanbul 4
Johannesburg 4
Lappeenranta 4
Madrid 4
Manchester 4
Mexico City 4
Mountain View 4
Nanjing 4
North Bergen 4
Pune 4
Querétaro 4
San Francisco 4
Sant'Andrea Bagni 4
Amman 3
Totale 11.527
Nome #
A case of SRSF2 mutation in chronic lymphocytic leukemia 517
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia 504
An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia 504
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 469
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 463
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 457
Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines 453
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 451
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia 446
PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL 442
Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC 438
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 412
Alterations of the FLT3 gene in acute promyelocytic leukemia: Association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol 410
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia 408
Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias 407
Identification of a potential hotspot DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation 406
Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin 401
Gentuzumab ozogamicin ("mylotarg") as a single agent for molecularly relapsed acute promyelocytic leukemia 396
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. 395
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 390
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4 387
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 381
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 380
Identification of a potential "Hotspot" DNA region in the RUNXI gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation 377
PML/RARA inhibits expression of HSP90 and its target AKT 366
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 266
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 244
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 198
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 184
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 174
Leukemia-Associated CD34/CD123/CD25/CD99-positive Immunophenotype Identifies FLT3-mutated Clones in Acute Myeloid Leukemia. 166
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 130
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes 130
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML 125
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 121
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 111
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 108
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 100
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 99
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 96
Transcriptional and metabolic dissection of ATRA-induced granulocytic differentiation in NB4 acute promyelocytic leukemia cells 92
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia 88
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation 87
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera 80
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies 79
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells 76
Treatment free remission in chronic myeloid leukemia: Lights and shadows 75
Editorial: Metabolic Rewiring in Leukemias 70
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 68
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients 65
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells 61
Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632–6658 38
Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia 37
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications 31
Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers 30
PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP 25
New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review 7
Totale 13.921
Categoria #
all - tutte 35.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 0 0 0 0 0 69 19
2021/2022419 23 48 15 18 15 21 26 16 24 45 43 125
2022/2023658 61 48 27 100 61 132 63 34 65 5 31 31
2023/2024308 60 13 31 8 20 69 16 2 13 9 12 55
2024/20251.014 54 241 111 84 11 70 119 46 88 52 86 52
2025/20262.161 180 72 282 176 194 83 351 245 275 283 20 0
Totale 13.921